Camlin Fine Sciences Ltd vs Saroja Pharma Industries India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 19, 2026

Key Highlights

The Latest Trading Price of Camlin Fine Sciences Ltd is ₹ 129.5 as of 18 Mar 15:30 . The P/E Ratio of Camlin Fine Sciences Ltd changed from 35 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Saroja Pharma Industries India Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Camlin Fine Sciences Ltd changed from ₹ 1782 crore on March 2021 to ₹ 3155 crore on March 2025 . This represents a CAGR of 12.10% over 5 yearsThe Market Cap of Saroja Pharma Industries India Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Camlin Fine Sciences Ltd for the Dec '25 is ₹ 460.13 crore as compare to the Sep '25 revenue of ₹ 464.42 crore. This represent the decline of -0.92% The revenue of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Camlin Fine Sciences Ltd for the Dec '25 is ₹ -2 crore as compare to the Sep '25 ebitda of ₹ 28.7 crore. This represent the decline of -106% The ebitda of Saroja Pharma Industries India Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Camlin Fine Sciences Ltd changed from ₹ -34.65 crore to ₹ -37.1 crore over 7 quarters. This represents a CAGR of 3.98% The net profit of Saroja Pharma Industries India Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Camlin Fine Sciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Saroja Pharma Industries India Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Camlin Fine Sciences Ltd

Camlin Fine Sciences Limited was originally incorporated on November 30, 1993 as a Private Limited Company with the name of 'Camlicon Consultants Private Limited'.
On June 1, 2006, the Company name was changed from Camlicon Consultants Private Limited to Camlin Fine Chemicals Private Limited.
As per the Scheme of Arrangement, the Fine Chemicals Division of Camlin Limited got demerged and transferred to the Company effective from July 01, 2006.
On August 11, 2006, the Company status was converted into Public Limited Company and the name was changed to Camlin Fine Chemicals Limited.
W.e.f. 27th August, 2011 name of the Company was changed from Camlin Fine Chemicals Limited to Camlin Fine Sciences Limited. The Company is one of the India's leading manufacturers and exporters of Bulk Drugs, Fine Chemicals and Food Grade products.

About Saroja Pharma Industries India Ltd

Saroja Pharma Industries India Ltd was originally incorporated as Private Limited, in the name and style of 'Saroja Pharma Industries India Private Limited' on January 14 , 2019 vide Certificate of Incorporation issued by the Registrar of Companies, Mumbai, Maharashtra.
Later on, Company was converted into Public Limited Company and due to conversion, name of the Company changed to 'Saroja Pharma Industries India Limited' through fresh Certificate of Incorporation dated April 18, 2023. Saroja Pharma Industries India Limited was founded in year, 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, upon becoming a globally integrated and highly regarded pharmaceutical and healthcare company, the two Promoters embarked on a journey to establish their business. In its initial stages, the Company operated as a Private Limited entity, operating with the name 'Saroja Pharma Industries India Private Limited.

FAQs for the comparison of Camlin Fine Sciences Ltd and Saroja Pharma Industries India Ltd

Which company has a larger market capitalization, Camlin Fine Sciences Ltd or Saroja Pharma Industries India Ltd?

Market cap of Camlin Fine Sciences Ltd is 2,487 Cr while Market cap of Saroja Pharma Industries India Ltd is 12 Cr

What are the key factors driving the stock performance of Camlin Fine Sciences Ltd and Saroja Pharma Industries India Ltd?

The stock performance of Camlin Fine Sciences Ltd and Saroja Pharma Industries India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Camlin Fine Sciences Ltd and Saroja Pharma Industries India Ltd?

As of March 19, 2026, the Camlin Fine Sciences Ltd stock price is INR ₹129.5. On the other hand, Saroja Pharma Industries India Ltd stock price is INR ₹31.15.

How do dividend payouts of Camlin Fine Sciences Ltd and Saroja Pharma Industries India Ltd compare?

To compare the dividend payouts of Camlin Fine Sciences Ltd and Saroja Pharma Industries India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.